Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge
- 5 June 2007
- Vol. 362 (2), 441-452
- https://doi.org/10.1016/j.virol.2007.01.001
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell FunctionJournal of Virology, 2006
- Reemergence of Monkeypox: Prevalence, Diagnostics, and CountermeasuresClinical Infectious Diseases, 2005
- Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in MiceJournal of Virology, 2005
- Comparative efficacy of replicating smallpox vaccine strains in a Murine Challenge ModelVaccine, 2005
- Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challengeVaccine, 2004
- Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch MutantsJournal of Virology, 2002
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001
- Mutations in the E2 Glycoprotein of Venezuelan Equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from Blood of MiceVirology, 2000
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990